Video

ASTRO 2011 and the Future of Radiation Oncology

Publish date: October 21, 2011

 

Dr. Anthony Zietman discusses how highlights of the ASTRO 2011 annual meeting bode well for men with prostate cancer. He also addresses the future of radiation oncology in an era of molecular targeting.

Recommended Reading

Factors Predict Erectile Function After Prostate Cancer Therapy
MDedge Hematology and Oncology
Radium-223 Could Alter Metastatic Prostate Cancer Management
MDedge Hematology and Oncology
Blue Skies and Pink Ribbons
MDedge Hematology and Oncology
Newer Radiotherapy for Prostate Cancer Less Harmful to Rectum
MDedge Hematology and Oncology
Hypofractionated Radiation Compares to Conventional Course for Prostate Cancer
MDedge Hematology and Oncology
Clinicians Slow to Embrace Sipuleucel-T for Prostate Cancer
MDedge Hematology and Oncology
Vitamin E Raises Prostate Cancer Risk
MDedge Hematology and Oncology
Celecoxib Gives No Boost to Hormone Therapy in Prostate Cancer
MDedge Hematology and Oncology
Denosumab Delays Bone Metastases in Castrate-Resistant Prostate Cancer
MDedge Hematology and Oncology
To screen, or not to screen
MDedge Hematology and Oncology